Another Way: RheumMadness 2022 DECT in Gout Scouting Report

Chances in the Tournament

Although there’s some tough competition in the Machine Region and beyond, we strongly believe the final bracket results will crystalize in our team’s favor. DECT promises to be an elegant non-invasive and cost-effective option to accurately diagnose gout—one of the most common conditions we encounter in our rheumatology careers. This potential is especially true in cases in which traditional methods have failed, those that are atypical and those that are refractory to standard treatment.

So what’s there to think about? Bet on DECT in Gout.

---

Leen Al Saleh, MD, is a first-year rheumatology fellow at MedStar/Georgetown Washington Hospital Center, Washington, D.C. 

Ajita Acharya, MD, is a first-year rheumatology fellow at MedStar/Georgetown Washington Hospital Center, Washington, D.C.

Elena Obreja, MD, is a second-year rheumatology fellow at MedStar/Georgetown Washington Hospital Center, Washington, D.C.

Akrithi U. Garren, MD, is a faculty rheumatologist at MedStar/Georgetown Washington Hospital Center, Washington, D.C.

References

1. Singh JA, Budzik JF, Becce F, et al. Dual-energy computed tomography vs. ultrasound, alone or combined, for the diagnosis of gout: A prospective study of accuracy. Rheumatology (Oxford). 2021 Oct 2;60(10):4861–4867.
2. Bongartz T, Glazebrook KN, Kavros SJ, et al. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2015 Jun;74(6):1072–1077.